SIX1 and breast carcinoma: Figure 1H demonstrates a trend towards increased median expression levels of SIX1 as breast cancer progresses to advanced stages, while Fig. 1I suggests a positive relationship between the number of lymph node metastases in breast cancer patients and elevated median expression levels of SIX1.